Cargando…
Current status of ischemic stroke treatment: From thrombolysis to potential regenerative medicine
Ischemic stroke is a major cause of death and disability worldwide and is expected to increase in the future with the aging population. Currently, there are no clinically available treatments for damage sustained during an ischemic stroke, but much research is being conducted in this area. In this r...
Autores principales: | Hurd, Mason Daniel, Goel, Isha, Sakai, Yasuyuki, Teramura, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517544/ https://www.ncbi.nlm.nih.gov/pubmed/34722837 http://dx.doi.org/10.1016/j.reth.2021.09.009 |
Ejemplares similares
-
Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal
por: Nepal, Gaurav, et al.
Publicado: (2019) -
Advance of Thrombolysis and Thrombectomy in Acute Ischemic Stroke
por: Nam, Hyo Suk, et al.
Publicado: (2023) -
Current status and prospects of organoid-based regenerative medicine
por: Choi, Woo Hee, et al.
Publicado: (2023) -
Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke
por: He, Yao‐De, et al.
Publicado: (2020) -
Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives
por: Arjmand, Babak, et al.
Publicado: (2021)